Apexigen
Liying Xie has over 19 years of work experience. Liying began their career in 2002 as the Hybridoma team supervisor at Epitomics. In 2021, they joined Apexigen as the Senior Manager of Antibody Development.
Liying Xie attended The University of British Columbia.
This person is not in any teams
Apexigen
Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products.